Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis

Leukemia and Lymphoma

Volumn 49, Issue 2, 2008, Pages 247-256

  Lee, Na Ri ^a   Song, Eun Kee ^a   Jang, Kyu Yun ^a   Choi, Ha Na ^a   Moon, Woo Sung ^a   Kwon, Keunsang ^a   Lee, Ju Hyung ^a   Yim, Chang Yeol ^a   Kwak, Jae Yong ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Diffuse large B cell lymphoma; FOXP3; Prognosis; Regulatory T cell

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MONOCLONAL ANTIBODY; PARAFFIN; PREDNISONE; PROTEIN ANTIBODY; PROTEIN BCL 6; TRANSCRIPTION FACTOR FOXP3; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RETROSPECTIVE STUDY; STATISTICAL MODEL; TISSUE MICROARRAY; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; T-LYMPHOCYTES, REGULATORY; TISSUE ARRAY ANALYSIS;

EID: 38849133434     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701824536     Document Type: Article

References (42)

1. Anderson, J. R., Armitage, J. O. and Weisenburger, D. D. (1998) Epidemiology of the non-Hodgkin's lymphomas: Distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol, 9, pp. 717-720.
2. Kang, Y. K., Kim, B. S., Kim, T. W., Ryu, M. H., Lee, S. S. and Ryoo, B. Y. (1999) Clinicopathologic characteristics of Korean non-Hodgkin's lymphomas based on REAL classification. J Korean Cancer Assoc, 31, pp. 641-652.
3. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med, 329, pp. 987-994.
4. Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E. and Fisher, R. I. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med, 346, pp. 1937-1947.
5. Colomo, L., Lopez-Guillermo, A., Perales, M., Rives, S., Martinez, A. and Bosch, F. (2003) Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood, 101, pp. 78-84.
6. Hans, C. P., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Delabie, J. and Ott, G. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, pp. 275-282.
7. Jacob, M. C., Piccinni, M. P., Bonnefoix, T., Sotto, M. F., Couderc, P. and Bensa, J. C. (1990) T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma: Reactivity toward the malignant clone. Blood, 75, pp. 1154-1162.
8. Lippman, S. M., Spier, C. M., Miller, T. P., Slymen, D. J., Rybski, J. A. and Grogan, T. M. (1990) Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course. Mod Pathol, 3, pp. 361-367.
9. Ansell, S. M., Stenson, M., Habermann, T. M., Jelinek, D. F. and Witzig, T. E. (2001) Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome. J Clin Oncol, 19, pp. 720-726.
10. Baecher-Allan, C., Viglietta, V. and Hafler, D. A. (2004) Human CD4+CD25+ regulatory T cells. Semin Immunol, 16, pp. 89-98.
11. Piccirillo, C. A. and Shevach, E. M. (2004) Naturally-occurring CD4+CD25+ immunoregulatory T cells: Central players in the arena of peripheral tolerance. Semin Immunol, 16, pp. 81-88.
12. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 155, pp. 1151-1164.
13. Hori, S., Takahashi, T. and Sakaguchi, S. (2003) Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv Immunol, 81, pp. 331-371.
14. Li, B., Samanta, A., Song, X., Furuuchi, K., Iacono, K. T. and Kennedy, S. (2006) FOXP3 ensembles in T-cell regulation. Immunol Rev, 212, pp. 99-113.
15. de Lafaille, M A Curotto and Lafaille, J. J. (2002) CD4(+) regulatory T cells in autoimmunity and allergy. Curr Opin Immunol, 14, pp. 771-778.
16. Hori, S., Nomura, T. and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, pp. 1057-1061.
17. Beyer, M. and Schultze, J. L. (2006) Regulatory T cells in cancer. Blood, 108, pp. 804-811.
18. Liyanage, U. K., Moore, T. T., Joo, H. G., Tanaka, Y., Herrmann, V. and Doherty, G. (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol, 169, pp. 2756-2761.
19. Woo, E. Y., Chu, C. S., Goletz, T. J., Schlienger, K., Yeh, H. and Coukos, G. (2001) Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res, 61, pp. 4766-4772.
20. Sasada, T., Kimura, M., Yoshida, Y., Kanai, M. and Takabayashi, A. (2003) CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: Possible involvement of regulatory T cells in disease progression. Cancer, 98, pp. 1089-1099.
21. Schaefer, C., Kim, G. G., Albers, A., Hoermann, K., Myers, E. N. and Whiteside, T. L. (2005) Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br J Cancer, 92, pp. 913-920.
22. Carreras, J., Lopez-Guillermo, A., Fox, B. C., Colomo, L., Martinez, A. and Roncador, G. (2006) High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood, 108, pp. 2957-2964.
23. Lee, A. M., Clear, A. J., Calaminici, M., Davies, A. J., Jordan, S. and MacDougall, F. (2006) Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol, 24, pp. 5052-5059.
24. Alvaro, T., Lejeune, M., Salvado, M. T., Bosch, R., Garcia, J. F. and Jaen, J. (2005) Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res, 11, pp. 1467-1473.
25. Gatter, K CWR (2001) Diffuse large B-cell lymphoma. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid tissue: World Health Organization Classification of Tumours, pp. 171-174. IARC Press, Lyon, France
26. Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I. and Connors, J. M. (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol, 17, pp. 1244-1253.
27. Kaplan, E. L. and Meier, P. (1958) Nonparametric-estimation from incomplete observations. J Am Stat Assoc, 53, pp. 457-481.
28. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep, 50, pp. 163-170.
29. Cox, D. R. (1972) Regression models and life-tables. J R Stat Soc, 34, pp. 187-220.
30. O'Garra, A., Vieira, P. L., Vieira, P. and Goldfeld, A. E. (2004) IL-10-producing and naturally occurring CD4+ Tregs: Limiting collateral damage. J Clin Invest, 114, pp. 1372-1378.
31. Jarnicki, A. G., Lysaght, J., Todryk, S. and Mills, K. H. (2006) Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor: Influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol, 177, pp. 896-904.
32. Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S. and Fehervari, Z. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev, 212, pp. 8-27.
33. Coffer, P. J. and Burgering, B. M. (2004) Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol, 4, pp. 889-999.
34. Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol, 4, pp. 330-336.
35. Huang, C. T., Workman, C. J., Flies, D., Pan, X., Marson, A. L. and Zhou, G. (2004) Role of LAG-3 in regulatory T cells. Immunity, 21, pp. 503-513.
36. Antony, P. A., Paulos, C. M., Ahmadzadeh, M., Akpinarli, A., Palmer, D. C. and Sato, N. (2006) Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J Immunol, 176, pp. 5255-5266.
37. Kabelitz, D., Wesch, D. and Oberg, H. H. (2006) Regulation of regulatory T cells: Role of dendritic cells and toll-like receptors. Crit Rev Immunol, 26, pp. 291-306.
38. Lim, H. W., Hillsamer, P., Banham, A. H. and Kim, C. H. (2005) Cutting edge: Direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol, 175, pp. 4180-4183.
39. Zhao, D. M., Thornton, A. M., DiPaolo, R. J. and Shevach, E. M. (2006) Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood, 107, pp. 3925-3932.
40. Yang, Z. Z., Novak, A. J., Stenson, M. J., Witzig, T. E. and Ansell, S. M. (2006) Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood, 107, pp. 3639-3646.
41. Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E. and Ansell, S. M. (2006) Attenuation of CD8+T-cell function by CD4+CD25+regulatory T cells in B-cell non-Hodgkin's lymphoma. Cancer Res, 66, pp. 10145-10152.
42. Hilchey, S. P., De, A., Rimsza, L. M., Bankert, R. B. and Bernstein, S. H. (2007) Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells. J Immunol, 178, pp. 4051-4061.